Literature DB >> 29692333

miR-33: A Metabolic Conundrum.

Anders M Näär1.   

Abstract

The miR-33 microRNAs (miRNAs) are crucial regulators of cholesterol/lipids, and may represent therapeutic targets for the treatment of atherosclerosis. A recent report by Price et al. showed that miR-33 knockout (KO) mice exhibit obesity, insulin resistance, and increased food intake, suggesting that metabolic regulation by miR-33 is more complex than was previously known.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  insulin resistance; miR-33; microRNA; obesity

Mesh：

Substances：

Year:  2018        PMID： 29692333      PMCID： PMC6151149          DOI： 10.1016/j.tem.2018.04.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN： 1043-2760            Impact factor:   12.015


  9 in total

Review 1.  MicroRNAs in metabolism and metabolic disorders.

Authors:  Veerle Rottiers; Anders M Näär
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

Review 2.  Metazoan MicroRNAs.

Authors:  David P Bartel
Journal:  Cell       Date:  2018-03-22       Impact factor: 41.582

Review 3.  MicroRNAs and lipid metabolism.

Authors:  Binod Aryal; Abhishek K Singh; Noemi Rotllan; Nathan Price; Carlos Fernández-Hernando
Journal:  Curr Opin Lipidol       Date:  2017-06       Impact factor: 4.776

4.  Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.

Authors:  Veerle Rottiers; Susanna Obad; Andreas Petri; Robert McGarrah; Marie W Lindholm; Joshua C Black; Sumita Sinha; Robin J Goody; Matthew S Lawrence; Andrew S deLemos; Henrik F Hansen; Steve Whittaker; Steve Henry; Rohn Brookes; S Hani Najafi-Shoushtari; Raymond T Chung; Johnathan R Whetstine; Robert E Gerszten; Sakari Kauppinen; Anders M Näär
Journal:  Sci Transl Med       Date:  2013-11-20       Impact factor: 17.956

5.  Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis.

Authors:  Nathan L Price; Noemi Rotllan; Alberto Canfrán-Duque; Xinbo Zhang; Paramita Pati; Noemi Arias; Jack Moen; Manuel Mayr; David A Ford; Ángel Baldán; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

6.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

7.  Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance.

Authors:  Nathan L Price; Abhishek K Singh; Noemi Rotllan; Leigh Goedeke; Allison Wing; Alberto Canfrán-Duque; Alberto Diaz-Ruiz; Elisa Araldi; Ángel Baldán; Joao-Paulo Camporez; Yajaira Suárez; Matthew S Rodeheffer; Gerald I Shulman; Rafael de Cabo; Carlos Fernández-Hernando
Journal:  Cell Rep       Date:  2018-02-20       Impact factor: 9.423

8.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

Authors:  Takahiro Horie; Tomohiro Nishino; Osamu Baba; Yasuhide Kuwabara; Tetsushi Nakao; Masataka Nishiga; Shunsuke Usami; Masayasu Izuhara; Naoya Sowa; Naoya Yahagi; Hitoshi Shimano; Shigenobu Matsumura; Kazuo Inoue; Hiroyuki Marusawa; Tomoyuki Nakamura; Koji Hasegawa; Noriaki Kume; Masayuki Yokode; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.

Authors:  Leigh Goedeke; Alessandro Salerno; Cristina M Ramírez; Liang Guo; Ryan M Allen; Xiaoke Yin; Sarah R Langley; Christine Esau; Amarylis Wanschel; Edward A Fisher; Yajaira Suárez; Angel Baldán; Manuel Mayr; Carlos Fernández-Hernando
Journal:  EMBO Mol Med       Date:  2014-09       Impact factor: 12.137
  9 in total
  5 in total

1.  Effect of Er Miao San on peritoneal macrophage polarisation through the miRNA-33/NLRP3 signalling pathway in a rat model of adjuvant arthritis.

Authors:  Min Liu; Xiangwen Meng; Zihua Xuan; Simeng Chen; Jin Wang; Zhiluo Chen; Jiayu Wang; Xiaoyi Jia
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.

Authors:  Yanyong Xu; Yang Xu; Yingdong Zhu; Huihui Sun; Cody Juguilon; Feng Li; Daping Fan; Liya Yin; Yanqiao Zhang
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

Review 3.  miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.

Authors:  Nathan L Price; Leigh Goedeke; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 12.137

4.  MOVAS Cells: A Versatile Cell Line for Studying Vascular Smooth Muscle Cell Cholesterol Metabolism.

Authors:  Ikechukwu Collins Esobi; Christian Barksdale; Caterra Heard-Tate; Rhonda Reigers Powell; Terri F Bruce; Alexis Stamatikos
Journal:  Lipids       Date:  2021-04-21       Impact factor: 1.646

Review 5.  Recent advances and future avenues in understanding the role of adipose tissue cross talk in mediating skeletal muscle mass and function with ageing.

Authors:  Andrew Wilhelmsen; Kostas Tsintzas; Simon W Jones
Journal:  Geroscience       Date:  2021-02-02       Impact factor: 7.713
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.